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WE investigated the in vitro effect of different forms
of acidosis (pH 7.0) on the formation of anaphylatox-
ins C3a and C5a. Metabolic acidosis due to addition of
hydrochloric acid (10 m mol/ml blood) or lactic acid
(5.5 m mol/ml)  to  heparin  blood  (N=12)  caused  sig-
nificant  activation  of  C3a  and  C5a  compared  to
control (both p=0.002). Respiratory acidosis activated
C3a (p=0.007) and C5a (p=0.003) compared to normo-
capnic  controls.  Making  blood  samples  with  lactic
acidosis hypocapnic resulted in a median pH of 7.37.
In this respiratory compensated metabolic acidosis,
C3a and C5a were not increased. These experiments
show that  acidosis  itself  and not  lactate  trigger  for
activation of complement components C3 and C5.
Key words: Acidosis, Alcalosis, Complement system, Com-
plement activation, Anaphylatoxins
Introduction
Hypoxia  and  reperfusion  cause  complement  activa-
tion in animal experiments and in clinical studies.
1–4
It  could  be  shown,  that  after  cytological  damage,
contact with cellular components such as mitochon-
dria, or excess of hydroxyl radicals, was responsible
for the activation  of the complement  system.
5,6 On
the  other hand,  in  vitro studies showed  a  comple-
ment activation  by acidosis or hypoxia only.
7–9 In a
previous  study,  we  found  complement  activation
induced by lactic acid.
10 The aim of the present  in
vitro study  was  to  investigate:  (1)  whether  lactate
itself or metabolic acidosis is responsible for activa-
tion, and (2) whether respiratory acidosis is also able
to activate the complement system.
Material and Methods
Blood samples (10 ml) from 12 healthy volunteers (6
male and 6 female, age: 28–40 years) were collected
and  50  IE  Heparin  was  added.  Each  sample  was
divided  into  eight  portions  and  placed  in  poly-
propylen tubes.
To investigate the influence of respiratory as well as
metabolic changes of pH on anaphylatoxin formation,
the  portions  were  equilibrated  with  different  gas
mixtures  and  supplemented  with  acids  resulting  in
marked changes in pH, pCO2 and base deficit (Table
1). Probes used as controls are No. 1–3. Four portions
were equilibrated with different gas mixtures at 37°C
to achieve normocapnia and normoxemia in control
portions (No. 3; Table 1), respiratory acidosis (No 6;
Table  1)  or  alcalosis  (No.  7,8;  Table  1).  For  this
purpose we modified the method of Siriwardhana et
al.
11 A 6 ml polypropylen tube (6 ml) was filled 1.5 to
2.0 ml blood and the end of a polypropylen tube with
an inner diameter of 3 mm was placed into the blood
a few millimetres above the bottom of the tube. Gas
mixtures  (O2,  N2,  CO2)  composed  from  medical
gases by flowmeters were put through the tube into
the  blood  sample.  Gas  flow  was  adjusted  to  one
bubble  per  second  for  20 min.  Foam  caused  by
bubbling  was  continuously  removed  by  a  suction
catheter placed above the blood level. After equilibra-
tion, the blood samples were transferred into differ-
ent tubes for further processing.
For metabolic acidosis 10 m mol hydrochloric acid
(No.  4;  Sigma-Aldrich,  Deisenhofen,  Germany)  or
5.5 m mol lactate (No: 5; Sigma-Aldrich, Deisenhofen,
Germany)  were  added  per ml  of  blood. To  achieve
compensated  metabolic  acidosis,  the  sample  was
equilibrated  with  a  hypocapnic  gas  mixture  for
20 min and then 5.5 m mol lactate per ml of blood was
added (No. 8).
Blood gas analysis, potassium and lactate concentra-
tions  were  measured  by  a  Radiometer Copenhagen
ABL 505 (Willich, Germany) using heparinised syrin-
ges after all samples were incubated at 37°C for 1 h. To
stop  complement  activation  after  incubation,  we
added 1 mg EDTA dissolved in purified water to each
sample.  Plasma  was  separated  by  centrifugation  at
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Anaphylatoxins C3a  and  C5a were determined as
previously  described.
12 C3a  enzyme  immunoassay
(EIA, Fa. Progen Biotechnik GmbH, Heidelberg, Ger-
many)  selectively  detects  C3a-desArg  using  mono-
clonal  antibodies.
13 C5a  was  determined  with  a
specific  sandwich  EIA  (Fa.  Behring,  Marburg,
Germany).
14
Statistical analysis
As most  of the  data  were not  normally distributed,
results were shown as medians with quartiles. Differ-
ences  between  controls  and  study  samples  were
assessed  using  the  Wilcoxon  test.  Statistical  sig-
nificance was assumed at p<0.05. All calculations and
tests  were  performed  with  the  SPSS-PC  software
(Chicago, Illinois, USA).
Results
Influence of incubation and equilibration
procedures
The  incubation  (No.  2)  and  equilibration  (No.  3)
procedure led to a measurable complement activation
compared  to  the  baseline  value  (No.  1;  Table  1).
Therefore the results were compared to controls of
the same handling method but without pH change.
Influence of metabolic and respiratory acidosis
Addition of hydrochloric as well as lactic acid caused
a marked metabolic acidosis. Concentrations of C3a,
C5a, and potassium were higher after incubation in
acidic  blood  compared  to  incubation  of  control
samples (No. 4 and 5 versus 2; Table 1). The potassium
concentration was lower in hydrochloric acidosis and
the  anaphylatoxin  concentrations  were  higher  than
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Table 1. Sample characteristics with different forms of acidosis after gas equilibration, addition of acids and 1h incubation time
at 37°C (N=12). Values are given as medians with quartiles
No Name Treatment Sample
procedure
pH value pCO2
(mmHg)
Base excess
(mEq/L)
Potassium
(mmol/L)
C3a
(m g/L)
C5a
(m g/L)
1 baseline value bubbling: No 7.36 50 0.0 4.1 128 0.13
(without incubation) additive: No 7.35/7.36 46/51 0.0/0.0 4.0/4.3 89/144 0.10/0.42
2 incubation control bubbling: No 7.30 50 –3.0 3.5 1595 1.4
additive: No 7.27/7.33 44/53 –2.4/–4.4 3.4/3.7 972/2070 0.9/2.6
3 bubble control bubbling: 78%  N2,
5% CO2,
17%  O2,
20min
7.30 51 –2.2 4.2 1025 1.4
additive: No 7.25/7.35 45/57 –0.8/–3.0 3.9/4.4 802/1257 0.8/2.8
4 HCI acidosis bubbling: No 7.01 78 –13.8 5.2 3360 21.8
additive: 10m mol HCl
per 1ml
sample
7.00/7.05 71/85 –12.4/–14.9 4.5/5.7 2860/3850 17.8/35.2
5 lactic acidosis bubbling: No 6.98 57 –17.1 6.4 2390 4.4
additive: 5.5m mol
lactate
per 1ml
sample
6.90/7.00 50/76 –16.2/–19.6 6.4/6.8 1975/2670 3.2/6.6
6 respiratory acidosis bubbling: 81%  N2,
19%  CO2,
20min
7.01 137 –5.2 4.3 1625 3.3
additive: No 6.97/7.04 123/158 –3.9/–7.3 3.9/4.7 1080/1868 1.8/4.2
7 respiratory alcalosis bubbling: 83%  N2,
17%  O2,
20min
7.54 20 –3.5 4.4 917 1.4
additive: No 7.49/7.57 17/23 –2.4/–4.0 4.1/4.7 825/1425 0.8/2.8
8 respiratory alcalosis
+ lactate
bubbling: 83%  N2,
17%  O2,
20min
7.37 28 –8.3 4.2 935 1.8
additive: 5.5m mol
lactate
per 1ml
sample
7.32/7.38 24/34 –7.3/–10.5 4.1/4.5 760/1150 1.3/5.4those  from  lactic  acidosis  (No.  4  versus  5).  The
anaphylatoxins were also higher in the hypercapnic
samples compared to the normocapnic controls (No.
6 versus 3; Table 1).
Influence of respiratory alkalosis
Respiratory alkalosis had no  influence on  anaphyla-
toxin concentration (No. 7 versus 3; Table 1).
Influence of respiratory compensated
metabolic acidosis
Although  measured  median  lactate  (13.1  versus
11.6 mmol/l) was not different in the lactic samples
(No. 5 versus 8; p=0.75), anaphylatoxins were higher
in  acidic samples compared to  respiratory compen-
sated normacidic samples (No. 5 versus 8; Table 1).
Discussion
The present in vitro study confirms the results of our
previous  study  that  acidosis  activates  complement
systems in heparin blood. The study shows that the
acidosis itself is the trigger for activation, because all
three forms of acidosis (hydrochloric or lactic acid or
carbon  dioxide)  lead  to  a  significant  increase  of
anaphylatoxin concentrations. Lactate did not lead to
an  activation,  when  acidosis  was  prevented  by
previous respiratory alcalosis (No. 8; Table 1).
Heparin was chosen as anticoagulant, because the
complement  may  be  markedly  spontaneously  acti-
vated  in  serum  and  both  EDTA  and  sodium  citrate
possibly influence pH values and impair complement
activation by calcium binding. Heparin however did
not  completely  prevent  spontaneous  complement
activation even after incubation  for 1 h at 37°C and
using  a  bubble  oxygenator  for  gas  equilibration.
Therefore  we  could  only  compare  the  extent  of
complement  activation  by  acidosis  to  the  sponta-
neous  activation  that  occurred  during  the  sample
preparation  procedure. As pH levels were similar in
lactic and hydrochloric acidosis, the activation of the
complement  system  was  stronger  for  hydrochloric
acid. The effects of the two acids on  the blood gas
analysis were different. Whereas lactate led to a larger
increase in  base deficit,  hydrochloric acid  caused a
stronger  release  of  carbon  dioxide. This  difference
may explain the stronger complement activation by
hydrochloric  acid.  Respiratory  acidosis  following
equilibration of blood samples with elevated carbon
dioxide concentrations also led to an activation of the
complement system compared to equilibration  con-
trol. In contrast to acidosis, respiratory alcalosis did
not have an influence on the complement system.
With the used in vitro setting, we could not clarify
the mechanism of anaphylatoxin  formation  by  acid-
osis. Complement activation in acidosis mediated by
membrane  fragments  of  damaged  erythrocytes
6 is
improbable,  as  we  could  show  that  activation  also
occurs in  plasma without  cell components.
10 There
are  other  arguments  against  membrane  fragment-
induced complement activation in acidosis, increased
potassium  values  and  a  slight  visible  hemolysis
occured  only  for  metabolic  but  not  for  respiratory
acidosis,  but  both  forms  of  acidosis  activate  the
complement  system. A  probable  mechanism  is  that
acidification of plasma inactivates complement prote-
ase inhibitors, this inhibition then results in comple-
ment activation in the absence or decreased presence
of functional inhibitors.
The  activation  of  the  complement  system  by
acidosis may explain the elevation of anaphylatoxins
in  different  diseases,  such  as  perinatal  asphyxia,
myocardial  infarction  and  shock.
3,4,15–17 These  pro-
cesses  probably  participate  in  the  pathogenesis  of
reperfusion injury.
4,17–19
Conclusion
We  have  shown  evidence  that  acidosis  activates
complement factors C3 and C5. This is independent
from the type of acidosis which occurs.
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